Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model

Posted: July 11, 2024 at 2:44 am

Certepetide shown to promote immune cell infiltration into tumors and inhibit metastasis Certepetide shown to promote immune cell infiltration into tumors and inhibit metastasis

Read the original:
Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model

Related Posts